Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mayne Pharma Group Limited has announced that The Vanguard Group, Inc. and its controlled entities, including Vanguard Investments Australia Ltd., have ceased to be substantial holders in the company as of June 20, 2025. This change in substantial holding reflects a shift in the voting power held by Vanguard Group, which now stands at 4.737%. The announcement may impact the company’s shareholder dynamics and influence its market positioning, as substantial holders often play a significant role in corporate governance and strategic decisions.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 935,971
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$408.7M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.